Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
- Written by PR Newswire
- Collaboration will evaluateAkeso's cadonilimab in combination withINOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the most common and aggressive form of brain cancer
- Novel combination therapy will be studied as part of the Phase II adaptive platform trial known as the INdividualized Screening trial of...














